An estimated 102.3 million American adults have total blood cholesterol values of 200mg/dL or higher according to the National Health and Nutrition Examination Survey III, conducted by the CDC/National Center for Health Statistics, Atlanta. Adults with total cholesterol levels of 200 to 239mg/dL are considered at high risk (borderline) for heart disease, while those with levels of 240mg/dL, or greater, are at high risk.
Statin drugs, such as lovastatin, pravastatin and simvastatin, effectively reduce cholesterol levels. However, recent concerns over the impact of these prescription medications on muscle tissue (including the heart) and on the liver have increased consumer interest in alternatives. This has led one supplier to look at ways to help manufacturers provide options.